- Home
- / CellaVision
CellaVision
Stock Price
KR246.5
2024-10-29
Market Capitalization
KR5.9 B
2024-10-29
Revenue
KR677.3 M
FY, 2023
CellaVision Summary
Company Summary
- Overview
- CellaVision develops and sells digital solutions for blood and body fluids analysis in health care services sector. The Company's solutions are based on digital image analysis technology, artificial intelligence, and information technology. Its products include CellaVision peripheral blood application, CellaVision advanced rbc application, and CellaVision remote review software.
- Type
- Public
- Status
- Active
- Founded
- 1994
- HQ
- Lund, SE | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Peter Wilson, VP Global Marketing
Julien Veyssy, VP Reagents Division
Adam Morell, VP Devices & Software
LocationsView all
14 locations detected
Lund, Skåne län HQ
Sweden
12 Mobilvägen
Durham, NC
United States
2530 Meridian Pkwy Suite 300
Sydney, NSW
Australia
44 Market St
SP
Brazil
Av. Paulista, 1048 - Bela Vista
Toronto, ON
Canada
2 Bloor St W #2120
Shanghai Shi
China
266 Hankou Rd, Huangpu Qu
CellaVision Financials
Summary Financials
- Revenue (Q3, 2024)
- kr178.7M
- Gross profit (Q3, 2024)
- kr131.7M
- Net income (Q3, 2024)
- kr31.1M
- Cash (Q3, 2024)
- kr137.7M
- EBIT (Q3, 2024)
- kr38.4M
- Enterprise value
- $5.8B